Three-Dimensional Bioprinting of Human Organs and Tissues: Bioethical and Medico-Legal Implications Examined Through a Scoping Review

Overview

Journal Bioengineering (Basel)

Date 2023 Sep 28

PMID 37760154

Authors

Giovanna Ricci

Filippo Gibelli

Ascanio Sirignano

Affiliations

Soon will be listed here.

Abstract

Three-dimensional bioprinting is a rapidly evolving technology that holds the promise of addressing the increasing demand for organs, tissues, and personalized medicine. By employing computer-aided design and manufacturing processes, 3D bioprinting allows for the precise deposition of living cells, biomaterials, and biochemicals to create functional human tissues and organs. The potential applications of this technology are vast, including drug testing and development, disease modeling, regenerative medicine, and ultimately, organ transplantation. However, as with any groundbreaking technology, 3D bioprinting presents several ethical, legal, and regulatory concerns that warrant careful consideration. As the technology progresses towards clinical applications, it is essential to address these challenges and establish appropriate frameworks to guide the responsible development of 3D bioprinting. This article, utilizing the Arksey and O'Malley scoping review model, is designed to scrutinize the bioethical implications, legal and regulatory challenges, and medico-legal issues that are intertwined with this rapidly evolving technology.

Citing Articles

Bioprinting and Intellectual Property: Challenges, Opportunities, and the Road Ahead.

Kantaros A, Ganetsos T, Petrescu F, Alysandratou E Bioengineering (Basel). 2025; 12(1).

PMID: 39851350 PMC: 11761581. DOI: 10.3390/bioengineering12010076.

Global Advancements in Bioactive Material Manufacturing for Drug Delivery: A Comprehensive Study.

Melo R, Nascimento Dari D, da Silva Aires F, Simao Neto F, Freire T, Fernandes B ACS Omega. 2025; 10(1):1207-1225.

PMID: 39829510 PMC: 11740136. DOI: 10.1021/acsomega.4c08669.

Three-Dimensional Organotypic Systems for Modelling and Understanding Molecular Regulation of Oral Dentogingival Tissues.

Lu E Int J Mol Sci. 2024; 25(21).

PMID: 39519105 PMC: 11546252. DOI: 10.3390/ijms252111552.

High-Speed Three-Dimensional-Digital Image Correlation and Schlieren Imaging Integrated With Shock Tube Loading for Investigating Dynamic Response of Human Tympanic Membrane Exposed to Blasts.

Alipanahi A, Luiz J, Rosowski J, Furlong C, Cheng J J Eng Sci Med Diagn Ther. 2024; 8(4):041101.

PMID: 39473970 PMC: 11515862. DOI: 10.1115/1.4066622.

Advances in 3D bioprinting for regenerative medicine applications.

Loukelis K, Koutsomarkos N, Mikos A, Chatzinikolaidou M Regen Biomater. 2024; 11:rbae033.

PMID: 38845855 PMC: 11153344. DOI: 10.1093/rb/rbae033.

References

Althabhawi N, Zainol Z . The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions' Patentability. Biomolecules. 2022; 12(1). PMC: 8773692. DOI: 10.3390/biom12010124. View

De Vries R, Oerlemans A, Trommelmans L, Dierickx K, Gordijn B . Ethical aspects of tissue engineering: a review. Tissue Eng Part B Rev. 2008; 14(4):367-75. DOI: 10.1089/ten.teb.2008.0199. View

Belk L, Tellisi N, MacDonald H, Erdem A, Ashammakhi N, Pountos I . Safety Considerations in 3D Bioprinting Using Mesenchymal Stromal Cells. Front Bioeng Biotechnol. 2020; 8:924. PMC: 7588840. DOI: 10.3389/fbioe.2020.00924. View

Dabrock P . Playing God? Synthetic biology as a theological and ethical challenge. Syst Synth Biol. 2009; 3(1-4):47-54. PMC: 2759421. DOI: 10.1007/s11693-009-9028-5. View

Xu Y, Xu Y, Bi B, Hou M, Yao L, Du Q . A moldable thermosensitive hydroxypropyl chitin hydrogel for 3D cartilage regeneration in vitro and in vivo. Acta Biomater. 2020; 108:87-96. DOI: 10.1016/j.actbio.2020.03.039. View

Rizzo M, Turco S, Spina F, Costantino A, Visi G, Baronti A . 3D printing and 3D bioprinting technology in medicine: ethical and legal issues. Clin Ter. 2023; 174(1):80-84. DOI: 10.7417/CT.2023.2501. View

Mathieu R . Jewish ethics and xenotransplantation. Xenotransplantation. 2016; 23(4):258-68. DOI: 10.1111/xen.12247. View

Lo B, Parham L . Ethical issues in stem cell research. Endocr Rev. 2009; 30(3):204-13. PMC: 2726839. DOI: 10.1210/er.2008-0031. View

Gilbert F, OConnell C, Mladenovska T, Dodds S . Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine. Sci Eng Ethics. 2017; 24(1):73-91. DOI: 10.1007/s11948-017-9874-6. View

10.

Harris A, Walker M, Gilbert F . Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine. BMC Med. 2022; 20(1):499. PMC: 9795739. DOI: 10.1186/s12916-022-02710-9. View

11.

Patuzzo S, Goracci G, Gasperini L, Ciliberti R . 3D Bioprinting Technology: Scientific Aspects and Ethical Issues. Sci Eng Ethics. 2017; 24(2):335-348. DOI: 10.1007/s11948-017-9918-y. View

12.

Ramadan Q, Zourob M . 3D Bioprinting at the Frontier of Regenerative Medicine, Pharmaceutical, and Food Industries. Front Med Technol. 2022; 2:607648. PMC: 8757855. DOI: 10.3389/fmedt.2020.607648. View

13.

Ravnic D, Leberfinger A, Koduru S, Hospodiuk M, Moncal K, Datta P . Transplantation of Bioprinted Tissues and Organs: Technical and Clinical Challenges and Future Perspectives. Ann Surg. 2017; 266(1):48-58. DOI: 10.1097/SLA.0000000000002141. View

14.

Kirillova A, Bushev S, Abubakirov A, Sukikh G . Bioethical and Legal Issues in 3D Bioprinting. Int J Bioprint. 2020; 6(3):272. PMC: 7557521. DOI: 10.18063/ijb.v6i3.272. View

15.

Faulkner A, Kent J, Geesink I, Fitzpatrick D . Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technology. Soc Sci Med. 2006; 63(9):2277-88. PMC: 7130933. DOI: 10.1016/j.socscimed.2006.06.006. View

16.

Neely E . The Risks of Revolution: Ethical Dilemmas in 3D Printing from a US Perspective. Sci Eng Ethics. 2015; 22(5):1285-1297. DOI: 10.1007/s11948-015-9707-4. View

17.

Patel K, Kim T, Mandakhbayar N, Singh R, Jang J, Lee J . Coating biopolymer nanofibers with carbon nanotubes accelerates tissue healing and bone regeneration through orchestrated cell- and tissue-regulatory responses. Acta Biomater. 2020; 108:97-110. DOI: 10.1016/j.actbio.2020.03.012. View

18.

Datta P, Cabrera L, Ozbolat I . Ethical challenges with 3D bioprinted tissues and organs. Trends Biotechnol. 2022; 41(1):6-9. DOI: 10.1016/j.tibtech.2022.08.012. View

19.

Garner J . Tissue engineering in surgery. Surgeon. 2004; 2(2):70-8. DOI: 10.1016/s1479-666x(04)80049-0. View

20.

Shakouri T, Cha J, Owji N, Haddow P, Robinson T, Patel K . Comparative study of photoinitiators for the synthesis and 3D printing of a light-curable, degradable polymer for custom-fit hard tissue implants. Biomed Mater. 2020; 16(1):015007. DOI: 10.1088/1748-605X/aba6d2. View